| Spectacular Eye Care Llc | |
|
509 S. Cherry Grove Ave, Suite C, Annapolis, MD 21401-4244 | |
| (410) 268-4393 | |
| Not Available |
| Full Name | Spectacular Eye Care Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 509 S. Cherry Grove Ave, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356438808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA1798 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Spectacular Eye Care Llc 509 S Cherry Grove Ave, Suite C, Annapolis, MD 21401-4244 Ph: (410) 268-4393 | Spectacular Eye Care Llc 509 S. Cherry Grove Ave, Suite C, Annapolis, MD 21401-4244 Ph: (410) 268-4393 |
News Archive
A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).
Obesity, which means having a high amount of extra body fat, is a widespread medical condition that affects more than 20 percent of the German population. Obesity is also a global epidemic: It is the number six cause of death in the world.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine.
Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.
› Verified 6 days ago
Dr. Ryan Shaun Sullivan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2321 Forest Dr, Annapolis, MD 21401 Phone: 410-266-3369 | |
Jonathan Jacesko, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. David A Byman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. Elizabeth C Mcmunn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-4378 | |
Dr. Jay Thompson Rorick, MD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 888 Bestgate Road, Suite 102, Annapolis, MD 21401 Phone: 410-571-7325 Fax: 410-571-7301 | |
Wenny Tan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 Annapolis Mall, Annapolis, MD 21401 Phone: 410-573-2095 | |
Anchor Eyecare Annapolis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 Fax: 410-349-0079 |